The CACNA1E gene gives your nerve cells instructions for part of a calcium channel, a gate that lets calcium enter during electrical signaling. This gene plays an important role in helping the brain control communication between nerve cells, muscle tone, and movement. If the CACNA1E gene does not work properly, brain signaling may become too easily triggered or less well coordinated, which can lead to seizures, developmental delay, low muscle tone, or unusual movements.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate activities in the body. Some genes provide the instructions for producing proteins, which are the functional parts of cells. Others mainly guide when certain processes happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. More detail on this topic is available in the LearnHub.
Overview
CACNA1EGene function
What if the gene works
The CACNA1E gene helps make a calcium channel used mainly by nerve cells. This channel lets calcium enter during electrical signals, which supports nerve communication and the release of brain chemical messengers.
Risk
What if the gene does not work
Some variants in the CACNA1E gene can cause early infant seizures, developmental delay, and unusual muscle stiffness or movements. Milder and more severe variants can affect how early symptoms appear and how strongly the brain and body are affected.
Treatment
What does that mean for your treatment
No CACNA1E-specific treatment or drug choice is currently established in clinical guidelines. Small reports suggest some people with CACNA1E-related seizures, especially with certain gain-of-function variants, may respond to topiramate, but this remains an emerging, nonstandard approach.
Gene function
What if the gene works
Small changes in voltage across a cell membrane help this gene do its job. The CACNA1E gene gives cells instructions for part of a calcium channel, a gateway that opens during electrical activity. This is especially important in the brain, where calcium entry helps link electrical signals to cell responses. It helps explain how brain cells send messages during everyday activity.
The CACNA1E gene helps build a channel that lets calcium move into cells when they become electrically active. This calcium flow acts as a signal that tells the cell to respond at the right moment.
In nerve cells, this channel helps turn electrical activity into chemical signaling between cells. That supports steady communication in brain networks used for movement, sensation, and thinking.
Calcium channels made with CACNA1E help shape when and how strongly a cell responds to stimulation. This fine tuning supports controlled cell firing and smooth coordination of signals.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the CACNA1E gene affect calcium channel function by changing how the channel folds, reaches the cell surface, or opens and closes. Some missense variants make it open too easily or stay open longer, while more disruptive variants can reduce calcium flow or stop the protein from working. This range can shape how early symptoms linked to the CACNA1E gene appear and how marked they may be.
How variants are linked to conditions
Pathogenic variants in the CACNA1E gene cause a rare neurological condition called CACNA1E-related developmental and epileptic encephalopathy. People with this diagnosis often have seizures starting in infancy, along with developmental delay, low muscle tone, and sometimes movement differences. Some may have milder neurodevelopmental features, but a CACNA1E-related developmental and epileptic encephalopathy diagnosis depends on the specific variant and the person’s clinical picture.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to CACNA1E. In families with a disease-causing change in this gene, the gene change itself is usually the main factor, and day-to-day lifestyle has not been shown to meaningfully change whether the condition happens.
Inheritance of CACNA1E variants
CACNA1E-related conditions usually follow an autosomal dominant inheritance pattern. This means a person with a disease-causing variant in the CACNA1E gene has a 50% chance of passing it to each child. In many families, though, CACNA1E gene inheritance starts with a new (de novo) variant that appears in the child and was not inherited from either parent. Once present, that variant can then be passed on to future children.
What does my CACNA1E result mean for my family?
For CACNA1E, the main known pattern is dominant, which means a close relative can also carry the same gene change even if symptoms differ. Parents, brothers, sisters, and children may have a chance of sharing it, so the result can matter for more than one person in a family. Some CACNA1E changes happen new in a child and are not found in either parent, so a positive result does not always mean it was inherited.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the CACNA1E gene, genetic testing usually reads DNA from a blood sample, saliva, or a cheek swab. Genetic testing for CACNA1E variants is often included in epilepsy panels, whole exome sequencing, or whole genome sequencing, and the lab classifies each finding by how likely it is to explain symptoms.
When should I consider getting a genetic test?
Genetic testing may be worth discussing if a baby or child has seizures that start early, repeated hard-to-control seizures, or developmental delays, especially along with unusual muscle tone or movement problems. A harmful change in the CACNA1E gene can help explain this pattern and may guide care and family counseling.
A genetic result is only one part of your health story
Genetic results can provide useful insight, yet what they reveal varies with the condition and the kind of variant involved. How the body works over time is also shaped by many influences, including lifestyle, the environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information is one part of the picture rather than a definite answer and is best considered alongside other aspects of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines because it can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect how people respond to medicines. It studies links between genes and medications to clarify why the same treatment may work differently in different people. With many drugs, genes can influence both how strongly a medicine works and how the body handles it. This information can support treatment choices that are more informed and more individualized. More details on this topic are available in the LearnHub.
Drugs influenced by the CACNA1E gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so questions about treatment, side effects, or new symptoms are best discussed with your doctor. CACNA1E has been studied in people with certain seizure conditions, but this has not led to standard medication decisions based on gene results.
History
The CACNA1E gene entered the medical literature in the 1990s, when researchers were sorting out the growing family of calcium channel genes in the nervous system. It was first identified through laboratory work that mapped and compared related channel genes across human and animal tissues. From these first observations, research expanded steadily. Over time, scientists linked CACNA1E to a distinct channel type and clarified how it fit within a broader naming system for these genes. Interest in the CACNA1E gene grew further in the late 2010s, when pathogenic variants were recognized in some children with early onset seizures and developmental differences. That work turned CACNA1E from a mainly research gene into one with clear clinical relevance.